選択的エストロゲン受容体分解薬
”. www.g1therapeutics.com. 2021年1月9日閲覧。
↑ “Orally Bioavailable SERD Shows Promise in Certain Breast Cancer Patients”. know.lww.com. 2021年1月9日閲覧。
↑ Bardia, Aditya; Linden, Hannah M.; Ulaner, Gary A.; Chandarlapaty, Sarat; Gosselin, Alice; Celanovic, Marina; Campone, Mario (2019-05-20). “Phase 1/2 dose-escalation and expansion study investigating SAR439859 +/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer.”. Journal of Clinical Oncology 37 (15_suppl): TPS1105. doi:10.1200/JCO.2019.37.15_suppl.TPS1105. ISSN 0732-183X. https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.TPS1105.
表示
編集